The ATTBF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ATTBF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ATTBF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ATTBF Detailed Price Forecast - CNN Money||View ATTBF Detailed Summary - Google Finance|
|View ATTBF Detailed Summary - Yahoo! Finance||View ATTBF Stock Research & Analysis - Zacks.com|
|View ATTBF Trends & Analysis - Trade-Ideas||View ATTBF Major Holders - Barrons|
|View ATTBF Call Transcripts - NASDAQ||View ATTBF Breaking News & Analysis - Seeking Alpha|
|View ATTBF Annual Report - CompanySpotlight.com||View ATTBF OTC Short Report - OTCShortReport.com|
|View ATTBF Fundamentals - TradeKing||View ATTBF SEC Filings - Bar Chart|
|View Historical Prices for ATTBF - The WSJ||View Performance/Total Return for ATTBF - Morningstar|
|View the Analyst Estimates for ATTBF - MarketWatch||View the Earnings History for ATTBF - CNBC|
|View the ATTBF Earnings - StockMarketWatch||View ATTBF Buy or Sell Recommendations - MacroAxis|
|View the ATTBF Bullish Patterns - American Bulls||View ATTBF Short Pain Metrics - ShortPainBot.com|
|View ATTBF Stock Mentions - StockTwits||View ATTBF Stock Mentions - PennyStockTweets|
|View ATTBF Stock Mentions - Twitter||View ATTBF Investment Forum News - Investor Hub|
|View ATTBF Stock Mentions - Yahoo! Message Board||View ATTBF Stock Mentions - Seeking Alpha|
|View Insider Transactions for ATTBF - SECform4.com||View Insider Transactions for ATTBF - Insider Cow|
|View ATTBF Major Holdings Summary - CNBC||View Insider Disclosure for ATTBF - OTC Markets|
|View Insider Transactions for ATTBF - Yahoo! Finance||View Institutional Holdings for ATTBF - NASDAQ|
|View ATTBF Stock Insight & Charts - FinViz.com||View ATTBF Investment Charts - StockCharts.com|
|View ATTBF Stock Overview & Charts - BarChart||View ATTBF User Generated Charts - Trading View|
Abattis Strengthens Management Team and Provides Company Updates
Posted on Tuesday September 11, 2018
Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to provide the following corporate updates. The Company is pleased to announce the appointment of Nicole Breitinger as the Company’s corporate secretary. Ms. Breitinger brings considerable experience to her role, having spent more than twenty years providing corporate services to companies across a range of industries.
Abattis Prepares to Launch New Products Through Vergence Naturals
Posted on Tuesday August 28, 2018
Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE: ATT / OTC: ATTBF) is pleased to announce that it plans to launch a new line of products designed to alleviate pain and inflammation through its wholly owned subsidiary, Vergence Naturals Ltd. (“Vergence”). The launch is anticipated to take place on Cyber Monday and the new product line will be the first of twelve products the Company hopes to launch over a 36-month period. “We are very proud to have developed two products that safely reduce pain and modulate inflammation.
Emerald Health Therapeutics Completes Acquisition of Licensed Dealer Northern Vine Canada
Posted on Wednesday August 15, 2018
Northern Vine is a Licensed Dealer (LD) under the provisions of the Canadian Controlled Drugs and Substances Act. The dealer license allows Emerald to participate in the growing market for cannabis analytical testing, which Emerald expects to grow in conjunction with increasing cannabis production volumes in Canada.
Abattis Completes Sale of Northern Vine Interest
Posted on Tuesday August 14, 2018
Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE: ATT / OTC: ATTBF) is pleased to announce that it has completed the sale (the “Sale”) of its 35% interest in Northern Vine Canada Inc. (“Northern Vine”) to Emerald Health Therapeutics, Inc. (TSXV:EMH / OTCQX:EMHTF) (“Emerald”) in exchange for $2 million in cash and $4 million in common shares of Emerald, 50% of which are free trading and 50% of which may be sold in 30 days. The share purchase agreement governing the Disposition (the “Agreement”) also provides that, upon Northern Vine and/or Emerald earning gross revenues of $10 million from the sale of products or provision of services to customers introduced by Abattis, Emerald will issue Abattis an additional $4 million in common shares of Emerald.